AIThe Next Webabout 1 hour ago
FDA clears Vitestro's Aletta robotic blood-draw device
1 min read
The FDA authorized Vitestro's Aletta through the De Novo pathway on 19 August 2026, making it the first standalone robotic device cleared to draw blood without a human hand on the needle. The Dutch trial showed a 95% first-stick success rate and 0.6% haemolysis rate.
Level
Hype check
Tap to vote and see what everyone thinks.
